The azimilide post-infarct survival evaluation (ALIVE) trial (Q42543714)

2 November 2017

title

The azimilide post-infarct survival evaluation (ALIVE) trial (English)

1 reference

2 November 2017

1

A J Camm

1 reference

2 November 2017

R Karam

2

1 reference

2 November 2017

C M Pratt

series ordinal

3

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

American Journal of Cardiology

2 November 2017

published in

1 reference

2 November 2017

volume

81

1 reference

2 November 2017

issue

6A

1 reference

2 November 2017

page(s)

35D-39D

1 reference

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900151-9

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900151-9

Survival with oral d-Sotalol in patients with left ventricular dysfunction after myocardial infarction: Rationale, design, and methods (the SWORD trial)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900151-9

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900151-9

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900151-9

Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900151-9

The novel class III antiarrhythmics NE-10064 and NE-10133 inhibit IsK channels expressed in Xenopus oocytes and IKs in guinea pig cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900151-9

Comparison of the rate-dependent properties of the class III antiarrhythmic agents azimilide (NE-10064) and E-4031: considerations on the mechanism of reverse rate-dependent action potential prolongation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900151-9

Comparison of the cardiac electrophysiologic effects of NE-10064 with sotalol and E-4031 and their modification by simulated ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900151-9

Azimilide (NE-10064) can prolong or shorten the action potential duration in canine ventricular myocytes: dependence on blockade of K, Ca, and Na channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900151-9

Blockade of human IsK channels expressed in Xenopus oocytes by the novel class III antiarrhythmic NE-10064.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900151-9

Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900151-9

Sudden cardiac death: etiologies, pathogenesis, and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900151-9

Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900151-9

Effect of age and gender on azimilide pharmacokinetics after a single oral dose of azimilide dihydrochloride.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900151-9

Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900151-9

10.1016/S0002-9149(98)00151-9

7 January 2021

Identifiers

DOI

1 reference

2 November 2017

1 reference